Evidence map›Paper›PMID 38374148›Full record

ArticleScientific reports2024

Glutamate is effective in decreasing opacity formed in galactose-induced cataract model.

Masaru Takashima, Shunki Yamamura, Chie Tamiya, Mayumi Inami, Yoshihiro Takamura, Masaru Inatani, Masaya Oki

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. WSeAnalytical and bioanalytical chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Masaru TakashimaDepartment of Industrial Creation Engineering, Graduate School of Engineering, University of Fukui, Fukui, Japan.
Shunki YamamuraDepartment of Industrial Creation Engineering, Graduate School of Engineering, University of Fukui, Fukui, Japan.
Chie TamiyaDepartment of Industrial Creation Engineering, Graduate School of Engineering, University of Fukui, Fukui, Japan.
Mayumi InamiTechnical Division, School of Engineering, University of Fukui, Fukui, Japan.
Yoshihiro TakamuraDepartment of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Masaru InataniDepartment of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Masaya OkiDepartment of Industrial Creation Engineering, Graduate School of Engineering, University of Fukui, Fukui, Japan. ma4sa6ya@u-fukui.ac.jp.
University of Fukui · JPFukui University of Technology · JP

Funding

University of Fukui LSI17102
6 · The paper itself

Abstract

Although cataract is the leading cause of blindness worldwide, the detailed pathogenesis of cataract remains unclear, and clinically useful drug treatments are still lacking. In this study, we examined the effects of glutamate using an ex vivo model in which rat lens is cultured in a galactose-containing medium to induce opacity formation. After inducing lens opacity formation in galactose medium, glutamate was added, and the opacity decreased when the culture was continued. Next, microarray analysis was performed using samples in which the opacity was reduced by glutamate, and genes whose expression increased with galactose culture and decreased with the addition of glutamate were extracted. Subsequently, STRING analysis was performed on a group of genes that showed variation as a result of quantitative measurement of gene expression by RT-qPCR. The results suggest that apoptosis, oxidative stress, endoplasmic reticulum (ER) stress, cell proliferation, epithelial-mesenchymal transition (EMT), cytoskeleton, and histones are involved in the formation and reduction of opacity. Therefore, glutamate may reduce opacity by inhibiting oxidative stress and its downstream functions, and by regulating the cytoskeleton and cell proliferation.

Indexed as

CataractLens, CrystallineAnimalsApoptosisEpithelial CellsGalactoseGlutamic AcidRatsGalactoseGlutamic Acid

Identifiers

PMID38374148
PMCPMC10876653
OpenAlexW4391925510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.